| 42.75 Delayed Data As of Jul 15 |  +0.35 / +0.83%Today’s Change | 37.12 Today|||52-Week Range 46.47 | -2.06% Year-to-Date |
| Previous close | 42.40 |
| Today’s open | 42.27 |
| Day’s range | 42.24 - 42.77 |
| Volume | 19,320,588 |
| Average volume (3 months) | 22,841,189 |
| Market cap | $235.4B |
| Earnings growth (last year) | -46.78% |
| Earnings growth (this year) | -2.94% |
| Earnings growth (next 5 years) | +7.99% |
| Revenue growth (last year) | +2.10% |
| P/E ratio | 21.9 |
| Price/Sales | 4.86 |
| Price/Book | 3.82 |
| Today’s change | Today’s % change | |
|---|---|---|
| MRKMerck | +1.23 | +1.54% |
| NVSNovartis | +1.08 | +1.22% |
| JNJJohnson & Johnson | +0.41 | +0.31% |
| AZNAstraZeneca | +0.01 | +0.02% |
| Next reporting date | July 30, 2019 |
| EPS forecast (this quarter) | $0.75 |
| Annual revenue (last year) | $53.6B |
| Annual profit (last year) | $11.2B |
| Net profit margin | 20.77% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Director, Chief Executive & Operating Officer Albert Bourla |
Chief Financial Officer & EVP-Business Operations Frank A. D'Amelio |
Corporate headquarters New York, New York |
